ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

France (CAC) 40 on Upward Trajectory Mid-Afternoon

Share On Facebook
share on Linkedin
Print

Having opened down on Friday and having spent the morning relatively flat on that opening level the France (CAC) 40 has recently taken a sharp upward turn. While it remains to be seen whether that impetus can be held for long enough to keep the CAC in positive territory for the day, losses have been clawed back and the index is currently 0.12% up on yesterday’s close.

Positive sentiment data for the Eurozone released a few hours ago may be helping to fuel the recent upswing. Overall economic confidence within the Eurozone is at its highest level since March 2011, with a December reading of 107.8, an improvement on November when the index showed 106.6. Services sector, construction sector, retail sector and consumer sentiment all showed improvement from November to December.

Among the individual constituents on the France 40, the day’s strongest gainer so far is Kering, the luxury goods holding that owns Gucci, Alexander McQueen and Puma, among several other brands, up 2.05%. Air Liquide, up 0.85% today, has announced the completion of the acquisition of Serdex, which produces natural active ingredients for cosmetics, from Germany’s Bayer for an undisclosed sum. Airbus is also 0.88% to the good.

The biggest and only major loser so far today has been pharma company Sanofi, which is currently registering a loss of 2.57% as the week heads into its closing straight. The fall comes on news that a U.S. judge has ruled to permanently block the sale of the company’s new cholesterol-lowering drug Praluent. The drug was found to infringe a patent held by U.S. peer Amgen for its rival product. Sanofi is relying heavily on a group of new products, including Praluent, it is trying to bring to market to offset the decline in sales of its blockbuster insulin medication Lantus.

Among the other fallers today are oil and gas industry companies Total, the integrated super major, down 0.56% and project manager and engineer to the industry Technip, with a 1.06% loss. Oil prices have softened today.

CLICK HERE TO REGISTER FOR FREE ON ADVFN, the world's leading stocks and shares information website, provides the private investor with all the latest high-tech trading tools and includes live price data streaming, stock quotes and the option to access 'Level 2' data on all of the world's key exchanges (LSE, NYSE, NASDAQ, Euronext etc).

This article was provided by Windsor Brokers. Click here for more information.


This area of the ADVFN.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ADVFN Plc. ADVFN Plc does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ADVFN.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ADVFN.COM and is not intended to be relied upon by users in making (or refraining from making) any investment decisions. Authors may or may not have positions in stocks that they are discussing but it should be considered very likely that their opinions are aligned with their trading and that they hold positions in companies, forex, commodities and other instruments they discuss.

Leave A Reply

 
Do you want to write for our Newspaper? Get in touch: newspaper@advfn.com